Inventor
PIETRA CLAUDIO
IT27 patents
⚠️ This page may combine multiple inventors who share the name “PIETRA CLAUDIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HELSINN HEALTHCARE SA
18 patentsUS10407390B2Sep 10, 2019
Asymmetric ureas and medical uses thereof
HELSINN HEALTHCARE SA1 citations72
US10208073B2Feb 19, 2019
Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator
HELSINN HEALTHCARE SA2 citations72
US9403772B2Aug 2, 2016
4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator
HELSINN HEALTHCARE SA4 citations72
US10577384B2Mar 3, 2020
Substituted asymmetric ureas as modulators of ghrelin receptor activity
HELSINN HEALTHCARE SA2 citations71
US9926337B2Mar 27, 2018
Substituted asymmetric ureas as modulators of ghrelin receptor activity
HELSINN HEALTHCARE SA2 citations71
US9546157B2Jan 17, 2017
Asymmetric piperidinyl-substituted ureas as medicines
HELSINN HEALTHCARE SA4 citations71
US12005056B2Jun 11, 2024
Centrally-active ghrelin agonist and medical uses thereof
HELSINN HEALTHCARE SA2 citations69
US12071421B2Aug 27, 2024
Process for the synthesis of substituted chloromethyl dialkylphosphates
HELSINN HEALTHCARE SA0 citations61
US11312698B2Apr 26, 2022
Fosnetupitant chloride hydrochloride having improved stability
HELSINN HEALTHCARE SA0 citations61
US12569476B2Mar 10, 2026
Piperidine urea derivatives for use as inotropic agents
HELSINN HEALTHCARE SA0 citations59
US12440485B2Oct 14, 2025
Centrally-active ghrelin agonist and medical uses thereof
HELSINN HEALTHCARE SA0 citations59
US11884646B2Jan 30, 2024
Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereof
HELSINN HEALTHCARE SA0 citations59
US11299472B2Apr 12, 2022
Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereof
HELSINN HEALTHCARE SA0 citations59
US10717721B2Jul 21, 2020
Substituted piperaziniums for the treatment of emesis
HELSINN HEALTHCARE SA0 citations51
US9908907B2Mar 6, 2018
Substituted piperaziniums for the treatment of emesis
HELSINN HEALTHCARE SA0 citations51
US9751836B2Sep 5, 2017
Asymmetric ureas and medical uses thereof
HELSINN HEALTHCARE SA0 citations51
US9358228B2Jun 7, 2016
Therapeutic combinations of netupitant and palonosetron
HELSINN HEALTHCARE SA0 citations51
US10501479B2Dec 10, 2019
Benzenesulfonyl-asymmetric ureas and medical uses thereof
HELSINN HEALTHCARE SA0 citations40